OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


 

Cole, A., Chan, A., Mujoomdar, M., Pichler, F. and Towse, A.

Briefing
August 2016

This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting, Tokyo. The panel session was entitled "How Can HTA in Asia-Pacific Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?" and was chaired by Franz Pichler (Eli Lilly & Company).

Siciliani, L.

Seminar Briefing
June 2016

This OHE Seminar Briefing summarises a seminar given by Professor Luigi Siciliani on waiting time policies in the health sector from an international perspective, and highlights which policies have worked well in the last decade in OECD countries. Professor Siciliani also touches on methods for comparing waiting times internationally and where the UK stands in the international figures. Finally, the Briefing discusses waiting time inequality by socioeconomic status.

Karlsberg Schaffer, S., Cubi-Molla, P., Devlin, N. and Towse, A.

Consulting Report
April 2016

This report details the views of a selection of experts in the fields of health and welfare economics on the cost-effectiveness threshold used by the National Institute for Health and Care Excellence (NICE) to decide which new medicines to recommend for use in the NHS, and the direction of future research in this area.

O'Neill, P. and Zamora, B.

Consulting Report
February 2016
The objective of this OHE Consulting Report was to outline trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to September 2015. This report was initiated and funded by Pfizer Ltd. It specifically considers whether there were changes in the trends due to the adoption of new policies by the SMC, namely the increased use of modifiers when assessing cost-effectiveness (e.g.

Feng, Y., Devlin, N., Shah, K., Mulhern, B. and Van Hout, B.

 

Research Paper
January 2016

Please note that a revised version of this paper has been accepted for publication and is forthcoming in Health Economics. There are some differences between the value set reported in the Health Economics version and the provisional value set reported in the OHE Research Paper version. Any use of the content of these materials is the sole responsibility of the user.

Devlin, N., Shah, K., Feng, Y., Mulhern, B. and Van Hout, B.

Research Paper
January 2016

Please note that a revised version of this paper has been accepted for publication and is forthcoming in Health Economics. There are some differences between the value set reported in the Health Economics version and the provisional value set reported in the OHE Research Paper version.

Sussex, J. and Hernandez-Villafuerte, K.

Research Paper
December 2015

This paper presents a model to capture the behaviour of health sector decision makers when making resource allocation decisions on the level and mix of healthcare production, while taking into consideration the maximum expenditure (budget) allowed by the government or the health system regulator.

The paper seeks to address two perennial policy and practical discussions in the UK National Health Service (NHS) (and elsewhere): how to cope with financial austerity; and the opportunity costs of reimbursing new health technologies.

Cole, A., Garrison, L., Mestre-Ferrandiz, J. and Towse, A.

Consulting Report
November 2015

The objective of this OHE Consulting Report was to understand and develop a view on the core principles that should govern how Real-World Data (RWD) is accessed or generated, and used credibly to produce or generate Real-World Evidence (RWE), thereby working toward a set of “international standards”.

Pages